Our co-founder Lara Zibners MD MMEd MBA has been selected to join the Springboard Enterprises 2025 Women’s Health Cohort!

Lara joins a cohort featuring 12 companies that are driving innovation in areas that differently, predominantly, or solely impact women. Over the next 3 months, the selected entrepreneurs will participate in an intensive accelerator program, working alongside a dedicated team of advisors to accelerate their next stage of growth. The program will conclude with a demo-day showcase where Lara will share our groundbreaking Callavid drug delivery technology on centre stage.

Program Sponsors: CVS Health, Eli Lilly and Company, Accenture, Amazon Web Services (AWS)